Podiatrist · Woodhaven, NY
NPI
1376549154
Since 2005
Specialty
Podiatrist
Code 213E00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
8612 Jamaica Ave
Woodhaven, NY, 11421
Phone (718) 846-7872
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
445 services
Medicare patients, 2024
121
Average age 74
Drug cost, 2024
$164K
5,639 prescriptions
Company payments, 2025
$125
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert J Castelli was code 99213 (office e&m - established), 251 times for 89 patients. In total Robert J Castelli billed 445 services in 15 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 251 | 89 | $75.90 | $19K |
| 99212 Office E&M - Established | Office | 39 | 25 | $49.64 | $1,936 |
| 73620 X-ray - Lower Extremity | Office | 39 | 24 | $25.69 | $1,002 |
| 20600 Joint Injection | Office | 23 | 12 | $57.38 | $1,320 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 22 | 12 | $0.09 | $2.03 |
| 99203 Office E&M - New | Office | 21 | 21 | $95.53 | $2,006 |
| 11730 Nail Procedure | Office | 12 | 11 | $87.33 | $1,048 |
| 99202 Office E&M - New | Office | 12 | 12 | $55.33 | $664 |
By year: 2022 $32K for 526 services; 2023 $28K for 411 services; 2024 $30K for 445 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert J Castelli prescribed most often to Medicare patients was Ammonium Lactate, with 1,347 prescriptions and refills. In total Robert J Castelli wrote 5,639 Medicare prescriptions that cost $164K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ammonium Lactate Generic | 1,347 | 1,477 | 324 | $34K |
| Ciclopirox Ciclopirox Olamine | 1,138 | 1,342 | 290 | $55K |
| Clotrimazole Generic | 591 | 593 | 192 | $18K |
| Mupirocin Generic | 491 | 499 | 161 | $3,428 |
| Ketoconazole Generic | 489 | 512 | 113 | $22K |
| Diclofenac Sodium Generic | 449 | 625 | 161 | $7,970 |
| Triamcinolone Acetonide Generic | 201 | 205 | 53 | $1,167 |
| Gabapentin Generic | 142 | 164 | 32 | $627 |
| Meloxicam Generic | 120 | 120 | 56 | $435 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 95 | 95 | 60 | $736 |
| Ssd Silver Sulfadiazine | 60 | 66 | 23 | $488 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 58 | 59 | 20 | $1,200 |
| Silver Sulfadiazine Generic | 52 | 53 | 22 | $476 |
| Naproxen Generic | 52 | 52 | 33 | $294 |
| Terbinafine Hcl Generic | 40 | 46 | 27 | $254 |
Brand drugs: 142 claims; generic drugs: 5,497 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert J Castelli $125 ($125 in general payments such as food, travel and fees) from 1 company. The largest payer was Paratek Pharmaceuticals, Inc. with $125.
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.